ZN-c3

· Zentalis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ZN-c3, covering 2024-09-19 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: ZN-c3 + Gemcitabine in Pancreatic Cancer [Phase 2]